These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 817629)

  • 21. Tuberculous meningitis due to primary drug-resistant Mycobacterium tuberculosis hominis.
    Bonforte RJ; Karpas CM; Gribetz I; Shanzer S
    Pediatrics; 1968 Dec; 42(6):969-75. PubMed ID: 4973145
    [No Abstract]   [Full Text] [Related]  

  • 22. Primary drug-resistant tuberculosis. Report of an outbreak.
    Steiner M; Chaves AD; Lyons HA; Steiner P; Portugaleza C
    N Engl J Med; 1970 Dec; 283(25):1353-8. PubMed ID: 4991512
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M
    Pol Med J; 1967; 6(3):604-9. PubMed ID: 6038083
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-susceptibility testing by laboratories participating in cooperative studies on the chemotherapy of tuberculosis.
    Wichelhausen RH; Robinson LB
    Am Rev Respir Dis; 1969 Jan; 99(1):1-7. PubMed ID: 4973586
    [No Abstract]   [Full Text] [Related]  

  • 25. Primary drug resistance in tuberculosis.
    Tizes R; Zaki MH; Katz S
    JAMA; 1970 Dec; 214(10):1887-8. PubMed ID: 4994250
    [No Abstract]   [Full Text] [Related]  

  • 26. Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
    Fairshter RD; Randazzo GP; Garlin J; Wilson AF
    Am Rev Respir Dis; 1975 Jul; 112(1):37-42. PubMed ID: 807140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spread of drug-resistant tubercle bacilli.
    Brander E; Aho K; Pätiälä J
    Am Rev Respir Dis; 1968 Sep; 98(3):407-15. PubMed ID: 4970549
    [No Abstract]   [Full Text] [Related]  

  • 28. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 29. [Epidemiological, microbiological and clinical significance of primary drug resistance in Mycobacterium tuberculosis (collective study)].
    Rudoĭ NM
    Probl Tuberk; 1974; (10):1-6. PubMed ID: 4213757
    [No Abstract]   [Full Text] [Related]  

  • 30. [Primary drug resistance of Mycobacterium tuberculosis in Kazakhstan].
    Krivtsova AE; Blagodarnyĭ IaA
    Probl Tuberk; 1974; (8):70-3. PubMed ID: 4277905
    [No Abstract]   [Full Text] [Related]  

  • 31. [A study on prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patents in 1972. Part 1. Comparison of result in 1972 with those in 1957, '59, '61, '63, '66 and '69].
    Kekkaku; 1975 Jan; 50(1):1-8. PubMed ID: 805311
    [No Abstract]   [Full Text] [Related]  

  • 32. [Primary drug resistance to standard drugs in previously untreated patients with pulmonary tuberculosis in Poznań in 1966-1969].
    Krzyzaniak J; Lubieńska B
    Gruzlica; 1971 Aug; 39(8):742-6. PubMed ID: 5097535
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary resistance to the major antitubercular drugs in pulmonary tuberculosis patients during 1961-1966].
    Jaroszewicz W; Buraczewska M; Pichulowa K; Pszonicka A; Zych D
    Gruzlica; 1968; 37(1):17-21. PubMed ID: 5720034
    [No Abstract]   [Full Text] [Related]  

  • 34. The trend of infection with drug-resistant strains of Mycobacterium tuberculosis among untreated patients. I. Isoniazid.
    Zaki MH; Lyons HA; Tizes R; Godinez F
    Am J Public Health Nations Health; 1969 Nov; 59(11):2056-66. PubMed ID: 4981880
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the practical value of tuberculosis resistance tests].
    Klein G; Primer G
    Prax Pneumol; 1969 Jan; 23(1):17-22. PubMed ID: 4978558
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary drug resistance: a continuing study of drug resistance in tuberculosis in a veteran population within the United States. IX. September 1969-September 1970.
    Hobby GL; Johnson PM; Boytar-Papirnyik V
    Am Rev Respir Dis; 1971 Jun; 103(6):842-4. PubMed ID: 4996847
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug sensitivity in pulmonary tuberculosis. Incidence of primary and acquired drug-resistance in 1960-1963.
    Selroos O; Brander L
    Acta Tuberc Pneumol Scand; 1965; 46(3):197-206. PubMed ID: 5880140
    [No Abstract]   [Full Text] [Related]  

  • 39. Some bacteriologic aspects of the epidemiology of pulmonary and extrapulmonary tuberculosis.
    Siddiqi SH; Stauffer JC; Ali MA; Middlebrook G
    Am J Epidemiol; 1976 Jan; 103(1):101-11. PubMed ID: 1247006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary drug resistance to PAS, INH and streptomycin in tubercle bacilli isolated from cases of open pulmonary tuberculosis.
    Rajvanshi VS; Tiagi GK
    Indian J Med Sci; 1968 Nov; 22(11):786-91. PubMed ID: 4974030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.